115
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Clinical Characteristics and Outcomes of Patients with Asthma–COPD Overlap in Japanese Patients with COPD

ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 2923-2929 | Published online: 12 Nov 2020

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020 Available from: http://www.ginasthma.org/. Accessed 713, 2020.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD; 2020 Available from: http://www.goldcopd.org/. Accessed 713, 2020.
  • GibsonPG, SimpsonJS. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(68):728–735. doi:10.1136/thx.2008.10802719638566
  • ZekiAA, SchivoM, ChanA, et al. The asthma-COPD overlap syndrome: a common clinical problem in the elderly. J Allergy. 2011;2011:861–926. doi:10.1155/2011/861926
  • AlshabanatA, ZafariZ, AlbanyanO, DairiM, FitzGeraldJM, ShortP. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.013606526336076
  • KauppiP, KupiainenH, LindqvistA, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279–285. doi:10.3109/02770903.2011.55557621323613
  • MiravitllesM, SorianoJB, AncocheaJ, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.00723597591
  • HardinM, SilvermanEK, BarrRG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):127. doi:10.1186/1465-9921-12-12721951550
  • MenezesAM, Montes de OcaM, Pérez-PadillaR, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-062224114498
  • KendzerskaT, SadatsafaviM, AaronSD, et al. Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: a population study of prevalence, incidence and mortality. PLoS One. 2017;12(3):e0173830.28301574
  • KobayashiS, HanagamaM, YamandaS, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2117–2123. doi:10.2147/COPD.S11364727660429
  • KobayashiS, HanagamaM, IshidaM, et al. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD network registry. Int J Chron Obstruct Pulmon Dis. 2018;13:3947–3955. doi:10.2147/COPD.S18290530584294
  • The Japanese Respiratory Society. Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease). 4th ed. Tokyo: Medical Review Co., Ltd.; 2013.
  • JonesPW, HardingG, BerryP, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • TsudaT, SuematsuR, KamoharaK, et al. Development of the Japanese version of the COPD assessment test. Respir Investig. 2012;50(2):34–39. doi:10.1016/j.resinv.2012.05.003
  • CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
  • MillerMR, HankinsonJ, BrusascoV, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
  • DweikRA, BoggsPB, ErzurumSC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST21885636
  • KandaY. Investigation of the freely-available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.24423208313
  • InoueH, NagaseT, MoritaS, et al. Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach. Int J Chron Obstruct Pulmon Dis. 2017;12:1803–1810. doi:10.2147/COPD.S13385928694693
  • CosioBG, SorianoJB, López-CamposJL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149(1):45–52. doi:10.1378/chest.15-105526291753
  • DonohueJF, HerjeN, CraterG, et al. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study. Int J Chron Obstruct Pulmon Dis. 2014;9:745–751. doi:10.2147/COPD.S4455225053884
  • TamadaT, SugiuraH, TakahashiT, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–2176. doi:10.2147/COPD.S8827426491283
  • KitaguchiY, KomatsuY, FujimotoK, et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283–289.22589579
  • FuJJ, GibsonPG, SimpsonJL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87(1):63–74. doi:10.1159/00035205324029561
  • YamauchiY, YasunagaH, MatsuiH, et al. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology. 2015;20(6):940–946. doi:10.1111/resp.1255625998444
  • ThoNV, ParkHY, NakanoY. Asthma-COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology. 2016;21(3):410–418. doi:10.1111/resp.1265326450153
  • GershonAS, CampitelliMA, CroxfordR, et al. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA. 2014;312(11):1114–1121. doi:10.1001/jama.2014.1143225226477
  • KendzerskaT, AaronSD, ToT, et al. Effectiveness and safety of inhaled corticosteroids in older individuals with chronic obstructive pulmonary disease and/or asthma. A population study. Ann Am Thorac Soc. 2019;16(10):1252–1262. doi:10.1513/AnnalsATS.201902-126OC31298938
  • SuzukiM, MakitaH, KonnoS, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194(11):1358–1365. doi:10.1164/rccm.201602-0353OC27224255
  • ZietkowskiZ, KucharewiczI, Bodzenta-LukaszykA. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Respir Med. 2005;99(7):816–824. doi:10.1016/j.rmed.2004.12.00815939243
  • ChanezP, VignolaAM, O’ShaugnessyT, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 1997;155(5):1529–1534. doi:10.1164/ajrccm.155.5.91548539154853
  • PascoeS, LocantoreN, DransfieldMT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomized controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi:10.1016/S2213-2600(15)00106-X25878028
  • Laniado-LaborínR. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6(1):209–224. doi:10.3390/ijerph601020919440278
  • PezzutoA, CaricoE. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: functional analysis. Clin Respir J. 2020;14(1):29–34. doi:10.1111/crj.1309631613417
  • PezzutoA, D’AscanioM, GriecoA, RicciA. Functional benefit of smoking cessation in severe COPD patients undergoing bronchial valve implantation. Eur J Intern Med. 2019;68:55–59. doi:10.1016/j.ejim.2019.07.03231387842